Abstract
Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.
Cite
CITATION STYLE
Eshaghi, A. R., Memari, N., Tang, P., Olsha, R., Farrell, D. J., Low, D. E., … Patel, S. N. (2013). Macrolide-resistant mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011. Emerging Infectious Diseases, 19(9), 1525–1527. https://doi.org/10.3201/eid1909.121466
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.